Modulating Effects of Spirulina platensis against Tilmicosin-Induced Cardiotoxicity in Mice

Abdelaziz E Ibrahim1, Mohamed Mohamed Abdel-Daim2

  • 1Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.

Cell Journal
|April 15, 2015
PubMed
Abstract

Insights

Spirulina platensis (SP) protects against tilmicosin (TIL)-induced cardiotoxicity in mice. SP administration normalized cardiac biomarkers and reduced oxidative stress, demonstrating its antioxidant and free radical-scavenging properties.

Area of Science:

  • Pharmacology
  • Toxicology
  • Natural Products

Background:

  • Tilmicosin (TIL), a macrolide antibiotic, treats bovine respiratory disease but can cause cardiotoxicity.
  • Overdoses of TIL have been linked to cardiac damage in animal models.
  • Spirulina platensis (SP) is a cyanobacterium with known antioxidant properties.

Purpose of the Study:

  • To investigate the protective effects of SP against TIL-induced cardiotoxicity.
  • To evaluate SP's efficacy in mitigating TIL-induced cardiac damage in mice.
  • To assess the role of SP's antioxidant activity in preventing TIL toxicity.

Main Methods:

  • An in vivo study involving 40 male albino mice divided into five groups.
  • Groups received saline, SP alone, TIL alone, or SP pretreatment followed by TIL.
  • Cardiac injury biomarkers, lipid peroxidation, and antioxidant biomarkers were analyzed.

Main Results:

  • Tilmicosin (TIL) administration significantly increased cardiac injury biomarkers and lipid peroxidation while decreasing antioxidant biomarkers.
  • SP administration normalized elevated serum levels of lactate dehydrogenase (LDH), creatine kinase (CK), and CK-MB.
  • SP reduced TIL-induced lipid peroxidation and oxidative stress in a dose-dependent manner.

Conclusions:

  • Spirulina platensis (SP) administration effectively minimized TIL-induced cardiotoxicity.
  • SP's protective effects are attributed to its potent antioxidant and free radical-scavenging activities.
  • SP shows potential as a therapeutic agent to counteract macrolide antibiotic-induced cardiac damage.

Related Concept Videos